News About: Pharm. Industry
Chance to extend health insurance benefits for NICUs to PICUs
As part of short-term measures for safety control followed by the Ewha Womans University Mokdong Hospital incident, there is a high chance for health insurance benefits for dispensing drugs by hospital pharmacists to ...
Chong Kun Dang exports biosimilar referencing anemia treatment to Japanese branch
Chong Kun Dang(CEO Young-Joo Kim) recently signed a business partnership agreement of ‘CKD-11101,’ a second-generation anemia treatment biosimilar, with a U.S. global pharmaceutical company’s Japanese branch. The agre...
Innovative pharmas gained 9% of sales with severe polarization
Last year, innovative pharmaceutical companies experienced an approximately 9% growth in sales, but reportedly had severe polarization in profitability.
Although general and foreign pharmaceutical companies had a gre...
No. of Korean pharmaceutical companies’ products rapidly decreases in the 20 most claimed products
In the top 20 most claimed products for the past 5 years, all the Korean products had reportedly lost the amount claimed.
According to the ‘Recent 5-Year Amount Claimed for Health Insurance Benefits’ published in the...
Top sales companies are Pfizer(KRW 751.6 billion), Novartis and Roche in order
Last year, Pfizer Pharmaceuticals Korea was ranked the top in sales among 17 overseas pharmaceutical companies.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 17 foreign pharmaceutical companies turne...
Dongwha Pharm & Pfizer Pharmaceuticals Korea extend sales & distribution agreement of CNS products
Dongwha Pharm(CEO/President Kwang-Ryul Yoo) announced it has extended a sales and distribution agreement of Pfizer Pharmaceuticals Korea’s major CNS(central nervous system) products at Pfizer Tower on the 10th of Apri...
Hanmi Pharm terminates development of Olita, “We’ll focus efforts on making global new drugs”
Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo) decided to terminate development of ‘Olita(generic name: olmutinib),’ a targeted therapy for lung cancer, and announced on the 13th that the company has been in progress ...
Listed pharmas’s salary gap higher than KRW 100 million between employees and officers
The salary gap between employees and officers at listed pharmaceutical companies was reportedly over KRW 100 million.
Yakup Shinmoon(www.yakup.com) analyzed 2018 business reports that listed pharmaceutical companies ...
6 pharmas including Yuhan Corporation spends more than KRW 30 billion into advertisements last year
A pharmaceutical company which spent the most in advertising was Yuhan Corporation with KRW 60.3 billion last year, and there were 6 pharmaceutical companies which spent KRW 30 billion or higher into advertising a yea...
Pharmaceutical and industrial experts gather at KINTEX this April
Sponsored by the Ministry of Food and Drug Safety and hosted by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and Kyungyon Exhibition Corp., KOREA PHARM & BIO 2018 will be held at Korea Internation...
